Showing 2,661 - 2,680 results of 2,809 for search '"General Hospital"', query time: 0.07s Refine Results
  1. 2661
  2. 2662
  3. 2663
  4. 2664
  5. 2665

    Non-Luminal Disease Score for Everolimus in Patients with Hormone Receptor‑positive and Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Mult... by Tan Y, Jiang H, Tian X, Ma F, Wang J, Zhang P, Xu B, Fan Y, Zhao W

    Published 2025-01-01
    “…Yujing Tan,1,* Hanfang Jiang,2,* Xinzhu Tian,1,* Fei Ma,1 Jiayu Wang,1 Pin Zhang,1 Binghe Xu,1 Ying Fan,1 Weihong Zhao3 1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, People’s Republic of China; 2Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, 100142, People’s Republic of China; 3Department of Medical Oncology, Chinese PLA General Hospital, Beijing, 100853, People’s Republic of China*These authors contributed equally to this workCorrespondence: Ying Fan; Weihong Zhao, Email fanying@cicams.ac.cn; zhaowh0818@163.comPurpose: This study aims to explore the role of the non-luminal disease score (NOLUS) for everolimus in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC).Methods: NOLUS has previously been established as an algorithm: NOLUS (0– 100) = − 0.45 × ER(%) − 0.28 × PR(%) + 0.27 × Ki67(%) + 73. …”
    Get full text
    Article
  6. 2666
  7. 2667
  8. 2668
  9. 2669
  10. 2670
  11. 2671
  12. 2672
  13. 2673

    A Machine Learning Model for Predicting Prognosis in HCC Patients With Diabetes After TACE by Wu L, Chen L, Zhang L, Liu Y, Ouyang D, Wu W, Lei Y, Han P, Zhao H, Zheng C

    Published 2025-01-01
    “…Linxia Wu,1– 3,* Lei Chen,1– 3,* Lijie Zhang,1,4,* Yiming Liu,1,5,* Die Ouyang,1 Wenlong Wu,5,6 Yu Lei,5,6 Ping Han,1 Huangxuan Zhao,1– 3 Chuansheng Zheng1– 3 1Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430022, People’s Republic of China; 2Department of Interventional Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430022, People’s Republic of China; 3Hubei Provincial Clinical Research Center for Precision Radiology & Interventional Medicine, Wuhan, Hubei Province, 430022, People’s Republic of China; 4Department of Interventional Radiology, The Fifth Medical Center of Chinese, PLA General Hospital, Beijing, 100039, People’s Republic of China; 5Department of Interventional Radiology, Auto Valley Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430056, People’s Republic of China; 6Department of Interventional Radiology, Jinyinhu Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430048, People’s Republic of China*These authors contributed equally to this workCorrespondence: Chuansheng Zheng; Huangxuan Zhao, Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430022, People’s Republic of China, Email hqzcsxh@sina.com; zhao_huangxuan@sina.comPurpose: Type II diabetes mellitus (T2DM) has been found to increase the mortality of patients with hepatocellular carcinoma (HCC). …”
    Get full text
    Article
  14. 2674
  15. 2675
  16. 2676
  17. 2677

    Absence of Standard Modifiable Risk Factors in Middle Eastern Patients with Atherosclerotic Cardiovascular Disease. The Jordan Absence of Standard Modifiable Risk Factors (SMuRF-Le... by Hammoudeh AJ, Aldalal’ah M, Smadi EA, Alrishoud D, Alomari A, Alkhawaldeh M, Rizik A, Okour MF, Araydah M

    Published 2025-02-01
    “…Ayman J Hammoudeh,1 Mo’men Aldalal’ah,2 Elham A Smadi,2 Dima Alrishoud,2 Amal Alomari,2 Mahmoud Alkhawaldeh,3 Aseel Rizik,4 Mahmoud Fakhri Okour,5 Mohammad Araydah6 1Department of Cardiology, Istishari Hospital, Amman, Jordan; 2Department of Clinical Medical Sciences, Yarmouk University School of Medicine, Irbid, Jordan; 3Department of Internal Medicine, King Abdullah University Hospital, Irbid, Jordan; 4Department of Medical Education, University of Jordan School of Medicine, Amman, Jordan; 5Department of Internal Medicine, Tutanji General Hospital, Amman, Jordan; 6Department of Internal Medicine, Istishari Hospital, Amman, JordanCorrespondence: Ayman J Hammoudeh, Department of Cardiology, Istishari Hospital, 44 Kindi Street, Amman, 11954, Jordan, Tel + 9626 500 1000, Fax + 9626 693 8833, Email a.hammoudeh@istisharihospital.comBackground: A growing number of individuals develop atherosclerotic cardiovascular disease (ASCVD) despite the absence of the standard modifiable risk factors (hypertension, diabetes, dyslipidemia, and cigarette smoking) (SMuRF-less patients). …”
    Get full text
    Article
  18. 2678
  19. 2679
  20. 2680